AFP and hepatocellular carcinoma: Serum alpha-fetoprotein (AFP) is extensively used as a tumor biomarker [21], and its promoter is therefore widely used to achieve HCC-specific gene expression with different enhancer/promoter combinations to confer high level while tight control of downstream gene expression in AFP-positive hepatoma cells [22-25].